文献速递糖尿病肥胖与代谢综合征

1型糖尿病青少年中与肥胖相关的肠道微生物变化

Gut Microbial Changes Associated With Obesity in Youth With Type 1 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

本研究在1型糖尿病青少年中比较瘦组(BMI 5%-<85%,n=27)与肥胖组(BMI≥95%,n=21)的肠道微生物和短链脂肪酸差异,采用鸟枪法宏基因组测序。肥胖组β多样性与瘦组不同(P=.013),普雷沃菌与拟杆菌比值更高(P=.0058),粪便短链脂肪酸均更高(P<.05)。

要点

  • 肥胖组与瘦组1型糖尿病青少年的肠道菌群β多样性存在差异(P=.013)。
  • 肥胖组普雷沃菌与拟杆菌比值高于瘦组(P=.0058)。
  • 肥胖组粪便短链脂肪酸均高于瘦组(P<.05)。

核心结论

  • 研究发现1型糖尿病青少年中与肥胖相关的肠道微生物组和微生物代谢物特征。
  • 这些发现可能有助于识别针对肠道微生物组来管理1型糖尿病肥胖的疗法。

研究设计与样本

  • 试点研究,分析瘦组(BMI 5%-<85%,n=27)与肥胖组(BMI≥95%,n=21)1型糖尿病青少年的粪便样本。
  • 采用鸟枪法宏基因组测序分析肠道微生物,并检测短链脂肪酸差异。
  • 受试者平均±标准差年龄15.3±2.2岁,糖化血红蛋白A1c 7.8±1.3%,糖尿病病程5.1±4.4年,42.0%为女性,94.0%为白人。

主要发现

  • 细菌群落组成显示按BMI分组的样本间多样性(β多样性)差异(P=.013)。
  • 肥胖组普雷沃菌与拟杆菌比值高于瘦组(P=.0058)。
  • 瘦组与肥胖组中显著丰富的分类群分布不同,肥胖组中Prevotella copri等分类群相对丰度增加。
  • 功能分析显示肥胖组支链氨基酸生物合成上调,瘦组支链氨基酸降解、酪氨酸代谢和次级胆汁酸生物合成上调。
  • 肥胖组粪便短链脂肪酸均高于瘦组(P<.05)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Obesity is prevalent in type 1 diabetes (T1D) and is problematic with higher risk for diabetes complications. It is unknown to what extent gut microbiome changes are associated with obesity and T1D. OBJECTIVE: This work aimed to describe the gut microbiome and microbial metabolite changes associated with obesity in T1D. We hypothesized statistically significant gut microbial and metabolite differences in lean T1D youth (body mass index [BMI]: 5%-<85%) vs those with obesity (BMI: ≥95%). METHODS: We analyzed stool samples for gut microbial (using metagenomic shotgun sequencing) and short-chain fatty acid (SCFA) differences in lean (n = 27) and obese (n = 21) T1D youth in a pilot study. The mean ± SD age was 15.3 ± 2.2 years, glycated hemoglobin A1c 7.8 ± 1.3%, diabetes duration 5.1 ± 4.4 years, 42.0% female, and 94.0% were White. RESULTS: Bacterial community composition showed between sample diversity differences (β-diversity) by BMI group (P = .013). There was a higher ratio of Prevotella to Bacteroides in the obese group (P = .0058). There was a differential distribution of significantly abundant taxa in either the lean or obese groups, including increased relative abundance of Prevotella copri, among other taxa in the obese group. Functional profiling showed an upregulation of branched-chain amino acid (BCAA) biosynthesis in the obese group and upregulation of BCAA degradation, tyrosine metabolism, and secondary bile acid biosynthesis in the lean group. Stool SCFAs were higher in the obese vs the lean group (P < .05 for all). CONCLUSION: Our findings identify a gut microbiome and microbial metabolite signature associated with obesity in T1D. These findings could help identify gut microbiome-targeted therapies to manage obesity in T1D.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ismail HM, Perera D, Mandal R, et al. Gut Microbial Changes Associated With Obesity in Youth With Type 1 Diabetes. J Clin Endocrinol Metab. 2025. PMID: 39078977. doi:10.1210/clinem/dgae529

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。